Antioxidant Behavioural Phenotype in the Immp2l Gene Knock-Out Mouse

Mitochondrial dysfunction is strongly associated with autism spectrum disorder (ASD) and the Inner mitochondrial membrane protein 2-like (IMMP2L) gene is linked to autism inheritance. However, the biological basis of this linkage is unknown notwithstanding independent reports of oxidative stress in association with both IMMP2L and ASD. To better understand IMMP2L’s association with behaviour, we developed the Immp2lKD knockout (KO) mouse model which is devoid of Immp2l peptidase activity. Immp2lKD −/− KO mice do not display any of the core behavioural symptoms of ASD, albeit homozygous Immp2lKD −/− KO mice do display increased auditory stimulus-driven instrumental behaviour and increased amphetamine-induced locomotion. Due to reports of increased ROS and oxidative stress phenotypes in an earlier truncated Immp2l mouse model resulting from an intragenic deletion within Immp2l, we tested whether high doses of the synthetic mitochondrial targeted antioxidant (MitoQ) could reverse or moderate the behavioural changes in Immp2lKD −/− KO mice. To our surprise, we observed that ROS levels were not increased but significantly lowered in our new Immp2lKD −/− KO mice and that these mice had no oxidative stress-associated phenotypes and were fully fertile with no age-related ataxia or neurodegeneration as ascertained using electron microscopy. Furthermore, the antioxidant MitoQ had no effect on the increased amphetamine-induced locomotion of these mice. Together, these findings indicate that the behavioural changes in Immp2lKD −/− KO mice are associated with an antioxidant-like phenotype with lowered and not increased levels of ROS and no oxidative stress-related phenotypes. This suggested that treatments with antioxidants are unlikely to be effective in treating behaviours directly resulting from the loss of Immp2l/IMMP2L activity, while any behavioural deficits that maybe associated with IMMP2L intragenic deletion-associated truncations have yet to be determined.

[1]  B. Balleine,et al.  Immp2l knockdown in male mice increases stimulus-driven instrumental behaviour but does not alter goal-directed learning or neuron density in cortico-striatal circuits in a model of Tourette syndrome and autism spectrum disorder , 2023, Behavioural Brain Research.

[2]  Yilun Ma,et al.  Immp2l Mutation Induces Mitochondrial Membrane Depolarization and Complex III Activity Suppression after Middle Cerebral Artery Occlusion in Mice , 2023, Current Medical Science.

[3]  J. Stülke,et al.  PAE viewer: a webserver for the interactive visualization of the predicted aligned error for multimer structure predictions and crosslinks , 2023, bioRxiv.

[4]  K. Gysling,et al.  Reactive oxygen species modulate locomotor activity and dopamine extracellular levels induced by amphetamine in rats , 2022, Behavioural Brain Research.

[5]  C. Kerns,et al.  Anxiety and Trauma-Related Disorders in Children on the Autism Spectrum , 2022, Current Psychiatry Reports.

[6]  M. Zhang,et al.  Guilingji Protects Against Spermatogenesis Dysfunction From Oxidative Stress via Regulation of MAPK and Apoptotic Signaling Pathways in Immp2l Mutant Mice , 2022, Frontiers in Pharmacology.

[7]  D. Schiller,et al.  Hippocampal contributions to social and cognitive deficits in autism spectrum disorder , 2021, Trends in Neurosciences.

[8]  Yongkang Ni,et al.  Identification of methylation markers for diagnosis of autism spectrum disorder , 2021, Metabolic Brain Disease.

[9]  S. Ovchinnikov,et al.  ColabFold: making protein folding accessible to all , 2022, Nature Methods.

[10]  Yilun Ma,et al.  [IMMP2L gene mutation activates mitochondrial apoptotic pathway to aggravate cerebral ischemic injury in mice]. , 2021, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[11]  P. Moya,et al.  Altered Grooming Syntax and Amphetamine-Induced Dopamine Release in EAAT3 Overexpressing Mice , 2021, Frontiers in Cellular Neuroscience.

[12]  Q. Xiong,et al.  Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease , 2021, Biomedicines.

[13]  V. Eapen,et al.  Tourette Syndrome Risk Genes Regulate Mitochondrial Dynamics, Structure, and Function , 2021, Frontiers in Psychiatry.

[14]  C. Mervis,et al.  Rare and low frequency genomic variants impacting neuronal functions modify the Dup7q11.23 phenotype , 2021, Orphanet Journal of Rare Diseases.

[15]  Fei Sun Commentary on "The Immp2l Mutation Causes Ovarian Aging Through ROS-Wnt/β-Catenin-Estrogen Pathway: Preventive Effect of Melatonin". , 2020, Endocrinology.

[16]  Conrad C. Huang,et al.  UCSF ChimeraX: Structure visualization for researchers, educators, and developers , 2020, Protein science : a publication of the Protein Society.

[17]  P. Paschou,et al.  Association of Genetic Variation in the 3'UTR of LHX6, IMMP2L, and AADAC With Tourette Syndrome , 2020, Frontiers in Neurology.

[18]  P. Li,et al.  The Immp2l mutation causes ovarian aging through ROS-Wnt/β-catenin-estrogen pathway: preventive effect of melatonin. , 2020, Endocrinology.

[19]  Z. Tümer,et al.  Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions , 2020, Frontiers in Neurology.

[20]  Z. Huo,et al.  Lycium barbarum polysaccharide protects against ethanol‐induced spermiotoxicity and testicular degeneration in Immp2l+/− mice , 2020, Andrologia.

[21]  M. Killingsworth,et al.  Scanning electron microscopy as a new tool for diagnostic pathology and cell biology. , 2019, Micron.

[22]  V. Eapen,et al.  First behavioural assessment of a novel Immp2l knockdown mouse model with relevance for Gilles de la Tourette syndrome and Autism spectrum disorder , 2019, Behavioural Brain Research.

[23]  N. Turner,et al.  Regulation of mitochondrial metabolism in murine skeletal muscle by the medium‐chain fatty acid receptor Gpr84 , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  J. George,et al.  A Mitochondrial Specific Antioxidant Reverses Metabolic Dysfunction and Fatty Liver Induced by Maternal Cigarette Smoke in Mice , 2019, Nutrients.

[25]  Ji Yoon Han,et al.  Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea , 2019, Annals of laboratory medicine.

[26]  L. Dell’Osso,et al.  Oxidative Stress, Maternal Diabetes, and Autism Spectrum Disorders , 2018, Oxidative medicine and cellular longevity.

[27]  L. Quek,et al.  Protein hypoacylation induced by Sirt5 overexpression has minimal metabolic effect in mice. , 2018, Biochemical and biophysical research communications.

[28]  T. Pringsheim,et al.  Using antipsychotics for behavioral problems in children , 2018, Expert opinion on pharmacotherapy.

[29]  D. Rossignol,et al.  Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder , 2018, Molecular Diagnosis & Therapy.

[30]  T. Bourgeron,et al.  Both rare and common genetic variants contribute to autism in the Faroe Islands , 2018, bioRxiv.

[31]  M. Ghaffari,et al.  Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders , 2018, Psychiatry Research.

[32]  L. Armengol,et al.  High Incidence of Copy Number Variants in Adults with Intellectual Disability and Co-morbid Psychiatric Disorders , 2018, Behavior genetics.

[33]  Nadia Passon,et al.  Genomic Deletion Involving the IMMP2L Gene in Two Cases of Autism Spectrum Disorder , 2018, Cytogenetic and Genome Research.

[34]  A. Anwer,et al.  MitoQ supplementation prevent long-term impact of maternal smoking on renal development, oxidative stress and mitochondrial density in male mice offspring , 2018, Scientific Reports.

[35]  B. Lei,et al.  Mitochondria‐targeted antioxidant SkQ1 improves spermatogenesis in Immp2l mutant mice , 2018, Andrologia.

[36]  S. Scherer,et al.  Association of IMMP2L deletions with autism spectrum disorder: A trio family study and meta‐analysis , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[37]  T. Hashimoto,et al.  Impact of Oxidative Stress and Newer Antiepileptic Drugs on the Albumin and Cortisol Value in Severe Motor and Intellectual Disabilities With Epilepsy , 2017, Journal of clinical medicine research.

[38]  E. Richard,et al.  Treatment with antioxidants ameliorates oxidative damage in a mouse model of propionic acidemia. , 2017, Molecular genetics and metabolism.

[39]  P. Li,et al.  Suppression of Inner Mitochondrial Membrane Peptidase 2-Like (IMMP2L) Gene Exacerbates Hypoxia-Induced Neural Death Under High Glucose Condition , 2017, Neurochemical Research.

[40]  V. Eapen,et al.  CTNNA3 discordant regulation of nested LRRTM3, implications for autism spectrum disorder and Tourette syndrome , 2017 .

[41]  Ann M. Graybiel,et al.  Neurobiology of rodent self-grooming and its value for translational neuroscience , 2015, Nature Reviews Neuroscience.

[42]  B. Lu,et al.  The Immp2l mutation causes age‐dependent degeneration of cerebellar granule neurons prevented by antioxidant treatment , 2015, Aging cell.

[43]  S. Faraone,et al.  Oxidative Stress and ADHD , 2015, Journal of attention disorders.

[44]  Paul G. King,et al.  Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette Syndrome , 2015, Brain Connect..

[45]  C. Bishop,et al.  Superoxide overproduction and kidney fibrosis: a new animal model , 2015, Einstein.

[46]  A. Molina,et al.  Examination of bioenergetic function in the inner mitochondrial membrane peptidase 2-like (Immp2l) mutant mice , 2014, Redox biology.

[47]  S. Gimelli,et al.  Interstitial 7q31.1 copy number variations disrupting IMMP2L gene are associated with a wide spectrum of neurodevelopmental disorders , 2014, Molecular Cytogenetics.

[48]  S. Liang,et al.  Family-based association study of ZNF533, DOCK4 and IMMP2L gene polymorphisms linked to autism in a northeastern Chinese Han population , 2014, Journal of Zhejiang University SCIENCE B.

[49]  Zeynep Tümer,et al.  Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome , 2014, European Journal of Human Genetics.

[50]  Viktoriya D. Nikolova,et al.  Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism , 2014, Behavioural Brain Research.

[51]  N. Turner,et al.  Contrasting metabolic effects of medium- versus long-chain fatty acids in skeletal muscle[S] , 2013, Journal of Lipid Research.

[52]  B. Lu,et al.  The role of nitric oxide signaling in food intake; insights from the inner mitochondrial membrane peptidase 2 mutant mice☆ , 2013, Redox biology.

[53]  V. Eapen,et al.  Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism , 2012, Translational Psychiatry.

[54]  C. Bishop,et al.  Oxidative stress is involved in age-dependent spermatogenic damage of Immp2l mutant mice. , 2012, Free radical biology & medicine.

[55]  Anne-Marie Le Sourd,et al.  Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2 , 2012, Nature.

[56]  P. Li,et al.  Deficiency in the inner mitochondrial membrane peptidase 2-like (Immp21) gene increases ischemic brain damage and impairs mitochondrial function , 2011, Neurobiology of Disease.

[57]  Joseph T. Glessner,et al.  A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder , 2011, Human Genetics.

[58]  N. Swerdlow,et al.  Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague–Dawley rats , 2011, Pharmacology, Biochemistry and Behavior.

[59]  C. Bishop,et al.  Mitochondrial peptidase IMMP2L mutation causes early onset of age‐associated disorders and impairs adult stem cell self‐renewal , 2011, Aging cell.

[60]  J. Morton,et al.  Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome , 2011, European Journal of Human Genetics.

[61]  D. Rossignol,et al.  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis , 2011, Molecular Psychiatry.

[62]  Jiannis Ragoussis,et al.  Characterization of a Family with Rare Deletions in CNTNAP5 and DOCK4 Suggests Novel Risk Loci for Autism and Dyslexia , 2010, Biological Psychiatry.

[63]  C. Bishop,et al.  Bladder dysfunction in a new mutant mouse model with increased superoxide--lack of nitric oxide? , 2010, The Journal of urology.

[64]  D. Shalom The Medial Prefrontal Cortex and Integration in Autism , 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[65]  Joseph T. Glessner,et al.  Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes , 2009, Molecular Psychiatry.

[66]  Tomi D. Berney,et al.  High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L–DOCK4 gene region in autism susceptibility , 2009, Molecular Psychiatry.

[67]  A. Zamyatnin,et al.  Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: Synthesis and in vitro studies , 2008, Biochemistry (Moscow).

[68]  E. Rolls,et al.  Computational models of schizophrenia and dopamine modulation in the prefrontal cortex , 2008, Nature Reviews Neuroscience.

[69]  C. Bishop,et al.  A Mutation in the Inner Mitochondrial Membrane Peptidase 2-Like Gene (Immp2l) Affects Mitochondrial Function and Impairs Fertility in Mice1 , 2008, Biology of reproduction.

[70]  J. Tauskela MitoQ--a mitochondria-targeted antioxidant. , 2007, IDrugs : the investigational drugs journal.

[71]  A. Minassian,et al.  Sensorimotor Gating Deficits in Adults with Autism , 2007, Biological Psychiatry.

[72]  G. Dawson,et al.  Evidence for multiple loci from a genome scan of autism kindreds , 2006, Molecular Psychiatry.

[73]  G. Baird,et al.  Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP) , 2006, The Lancet.

[74]  N. Green,et al.  Substrate specificity of inner membrane peptidase in yeast mitochondria , 2006, Molecular Genetics and Genomics.

[75]  Eric Fombonne,et al.  Epidemiology of autistic disorder and other pervasive developmental disorders. , 2005, The Journal of clinical psychiatry.

[76]  Eric Fombonne,et al.  Pervasive developmental disorders in preschool children: confirmation of high prevalence. , 2005, The American journal of psychiatry.

[77]  D. Vaux,et al.  Mature DIABLO/Smac is produced by the IMP protease complex on the mitochondrial inner membrane. , 2005, Molecular biology of the cell.

[78]  M. Cuccaro,et al.  Repetitive behaviors in autism: relationships with associated clinical features. , 2005, Research in developmental disabilities.

[79]  E Maestrini,et al.  Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects , 2005, Journal of Medical Genetics.

[80]  F. Richer,et al.  Association between 7q31 markers and tourette syndrome , 2004, American journal of medical genetics. Part A.

[81]  L. Peltonen,et al.  A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. , 2002, American journal of human genetics.

[82]  P. Cavadini,et al.  Mitochondrial processing peptidases. , 2002, Biochimica et biophysica acta.

[83]  J. Gilbert,et al.  Genomic screen and follow-up analysis for autistic disorder. , 2002, American journal of medical genetics.

[84]  Stephen J. Guter,et al.  A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. , 2001, American journal of human genetics.

[85]  N. Swerdlow,et al.  Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges , 2001, Psychopharmacology.

[86]  K. Davis,et al.  Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. , 2001, American journal of human genetics.

[87]  S. Scherer,et al.  Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. , 2001, American journal of human genetics.

[88]  S. Folstein,et al.  An autosomal genomic screen for autism. , 1999, American journal of medical genetics.

[89]  J. Gilbert,et al.  Genetic studies of autistic disorder and chromosome 7. , 1999, Genomics.

[90]  C. Francks,et al.  A full genome screen for autism with evidence for linkage to a region on chromosome 7q. International Molecular Genetic Study of Autism Consortium. , 1998, Human molecular genetics.

[91]  P. Paschou,et al.  Gilles de la Tourette syndrome , 2017, Nature Reviews Disease Primers.

[92]  D. Comings,et al.  Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3. , 1996, American journal of human genetics.

[93]  A. Schneider,et al.  Purified inner membrane protease I of yeast mitochondria is a heterodimer. , 1994, The Journal of biological chemistry.

[94]  T. Fox,et al.  A mitochondrial protease with two catalytic subunits of nonoverlapping specificities. , 1993, Science.

[95]  P. Solomon,et al.  Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat , 1984 .

[96]  T. Manivasagam,et al.  Role of Oxidative Stress and Antioxidants in Autism. , 2020, Advances in neurobiology.

[97]  D. Escalier [Knockout mice in the service of reproduction]. , 2008, Gynecologie, obstetrique & fertilite.

[98]  D. Murphy,et al.  Analyzing grooming microstructure in neurobehavioral experiments , 2007, Nature Protocols.

[99]  L. Peltonen,et al.  A heterogeneity-based genome search meta-analysis for autism-spectrum disorders , 2006, Molecular Psychiatry.

[100]  E. Gershon,et al.  Regional meta-analysis of published data supports linkage of autism with markers on chromosome 7 , 2002, Molecular Psychiatry.